Folic acid supplementation during early hepatocarcinogenesis: Cellular and molecular effects

International Journal of Cancer

Volumn 129, Issue 9, 2011, Pages 2073-2082

  Chagas, Carlos Eduardo Andrade ^a   Bassoli, Bruna Kempfer ^a   De Souza, Camila Alexandre Soares ^a   Deminice, Rafael ^a   Júnior, Alceu Afonso Jordão ^a   Paiva, Sérgio Alberto Rupp ^b   Dagli, Maria Lúcia Zaidan ^a   Ong, Thomas Prates ^a   Moreno, Fernando Salvador ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

chemoprevention; folic acid supplementation; hepatocarcinogenesis; preneoplastic lesions

Indexed keywords

DIETHYLNITROSAMINE; FOLIC ACID; GLUTATHIONE TRANSFERASE; MYC PROTEIN; N (2 FLUORENYL)ACETAMIDE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DNA METHYLATION; DRUG DOSE COMPARISON; GENE EXPRESSION; LIVER CANCER; LIVER CARCINOGENESIS; MALE; MICRODISSECTION; NONHUMAN; PARTIAL HEPATECTOMY; PRECANCER; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; BODY WEIGHT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHEMOPREVENTION; DIETARY SUPPLEMENTS; DNA DAMAGE; DNA METHYLATION; FOLIC ACID; GENE EXPRESSION; GENES, MYC; GLUTATHIONE TRANSFERASE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; ORGAN SIZE; PRECANCEROUS CONDITIONS; RATS; RATS, WISTAR; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE;

EID: 80052261179     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25886     Document Type: Article

References (50)

1. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM,. The global burden of cancer: priorities for prevention. Carcinogenesis 2010; 31: 100-110.
2. Kensler TW, Quian GS, Chen JG, Groopman JD,. Translational strategies for cancer prevention in liver. Nat Rev Cancer 2003; 3: 321-9. (Pubitemid 37328852)
3. Kim Y-I,. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res 2007; 51: 267-92. (Pubitemid 47083662)
4. Cravo ML, Mason JB, Dayal Y, Hutchinson M, Smith D, Selhub J, Rosenberg IH,. Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res 1992; 52: 5001-6.
5. Kim Y-I, Salomon RN, Graeme-Cook F, Choi SW, Smith DE, Dallal GE, Mason JB,. Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut 1996; 39: 732-40. (Pubitemid 26426477)
6. Min mouse. Cancer Res 2000; 60: 5434-40.
7. Song J, Sohn KJ, Medline A, Ash C, Gallinger S, Kim Y-I,. Chemopreventive effects of dietary folate on intestinal polyps on Apc+/-Msh2-/-mice. Cancer Res 2000; 60: 3191-9. (Pubitemid 30407916)
8. Lindzon GM, Medline A, Sohn KJ, Depeint F, Croxford R, Kim Y-I,. Effect of folic acid supplementation on the progression of colorectal aberrant crypt foci. Carcinogenesis 2009; 30: 1536-43.
9. Xiao SD, Meng XJ, Shi Y, Hu YB, Zhu SS, Wang CW,. Interventional study of high dose folic acid in gastric carcinogenesis in beagles. Gut 2002; 50: 61-4. (Pubitemid 34028304)
10. Fei SJ, Xiao SD, Peng YS, Chen XY, Shi Y,. Chemopreventive effects of refecoxib and folic acid on gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in rats. Chin J Dig Dis 2006; 7: 134-40. (Pubitemid 43983744)
11. Kim Y-I,. Does a high folate intake increase the risk of breast cancer? Nutr Rev 2006; 64: 468-75. (Pubitemid 44582079)
12. Miller EC, Plescia AM, Miller JA, Heidelberger C,. The metabolism of methylated aminoazo dyes. I. The demethylation of 3-methyl-4-dimethyl-C14 amino-azobenzene in vivo. J Biol Chem 1952; 196: 863-74.
13. Poirier LA,. Hepatocarcinogenesis by diethylnitrosamine in rats fed high dietary levels of lipotropes. J Natl Cancer Inst 1975; 54: 137-40.
14. Tsujiuchi T, Kobayashi E, Nakae D, Mizumoto Y, Andoh N, Kitada H, Ohashi K, Fukuda T, Kido A, Tsutsumi M, Denda A, Konishi Y,. Prevention by methionine of enhancement of hepatocarcinogenesis by coadministration of choline-deficient L -amino acid-defined diet and ethinonine in rats. Jpn J Cancer Res 1995; 86: 1136-41.
15. Pereira MA, Wang W, Kramer PM, Tao L,. Prevention by methionine of dichloroacetic acid-induced liver cancer and DNA hypomethylation in mice. Toxicol Sci 2004; 77: 243-8. (Pubitemid 38262596)
16. Du Y-P, Peng J-S, Sun A, Tang Z-H, Ling W-H, Zhu H-I,. Assessment of the effect of betaine on p16 and c-myc DNA methylation and mRNA expression in a chemical induced rat liver cancer model. BMC Cancer 2009; 9: 261-70.
17. Pascale RM, Simile MM, De Miglio MR, Feo F,. Chemoprevention of hepatocarcinogenesis: S-adenosyl- L -methionine. Alcohol 2002; 27: 193-8.
18. Farber E, Rubin H,. Cellular adaptation in the origin and development of cancer. Cancer Res 1991; 51: 2751-61.
19. Farber E, Sarma DS,. Biology of disease. Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest 1987: 56: 4-22. (Pubitemid 17011166)
20. Bannasch P, Haertel T, Su Q,. Significance of hepatic preneoplasia in risk identification and early detection of neoplasia. Toxicol Pathol 2003; 31: 134-9. (Pubitemid 36169431)
21. Andersen JB, Loi R, Perra A, Factor VM, Ledda-Columbano GM, Columbano A, Thorgeirsson SS,. Progenitor-derived hepatocellular carcinoma model in the rat. Hepatology 2010; 51: 1401-9.
22. National Research Council. Nutrient requirements of the laboratory rat. In: National Research Council. Nutrient requirements of laboratory animals, 4th edn. Washington: National Academy Press, DC, 1995. 11-79.
23. Ong TP, Heidor R, De Conti A, Dagli MLZ, Moreno FS,. Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMG-CoA reductase. Carcinogenesis 2005; 27: 1194-203.
24. Bannasch P, Zerban H,. Tumor of the liver. In:, Turusov VS, Mohr U, eds. Pathology of tumors in laboratory animals. Lyon: IARC, 1990. 199-240.
25. Squire RA, Levitt MH,. Report of workshop on classification of specific hepatocellular lesions in rats. Cancer Res 1975; 35: 3214-23.
26. Mazzantini RP, De Conti A, Moreno FS,. Persistent and remodeling hepatic preneoplastic lesions present differences in cell proliferation and apoptosis, as well as in p53, Bcl-2 and NF-kappaB pathways. J Cell Biochem 2008; 103: 538-46. (Pubitemid 351171924)
27. Grasl-Kraupp B, Bursch W, Ruttkay-Nedecky B, Wagner A, Lauer B, Shulte-Herrmann R,. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc Natl Acad Sci USA 1994; 91: 9995-9. (Pubitemid 24311935)
28. Poirier LA, Wise CK, Delongchamp RR, Sinha R,. Blood determination of S-adenosylmethionine, S-adenosylhomocysteine, and homocysteine: correlation with diet. Cancer Epidemiol Biomarkers Prev 2001; 10: 649-55.
29. Barbisan LF, Scolastici C, Miyamoto M, Salvadori DM, Ribeiro LR, Da Eira AF, Camargo JL,. Effects of crude extracts of Agaricus blazei on DNA damage on rat liver carcinogenesis induced by diethylnitrosamine. Genet Mol 2003; 2: 295-308. (Pubitemid 38846565)
30. Tao T, Wang W, Kramer PM, Lubet RA, Steele VE, Pereira MA,. Modulation of DNA hypomethylation as a surrogate endpoint biomarker for chemoprevention of colon cancer. Mol Carcinogenesis 2004; 39: 79-84. (Pubitemid 38167111)
31. Simile MM, Pagnan G, Pastorino F, Brignole C, De Miglio MR., Muroni MR, Asara G, Frau M, Seddaium MA, Calvisi DF, Feo F, Ponzoni M, Pascale RM,. Chemopreventive N-(4-hydroxyphenyl)retinamide(fenretinide) targets deregulated NF-{kappa}B and Mat1A genes in the early stages of rat liver carcinogenesis. Carcinogenesis 2005; 26: 417-27. (Pubitemid 40246564)
32. Dhingra S, Bansal MP,. Modulation of hypercholesterolemia-induced alterations in apolipoprotein B and HMG-CoA reductase expression by selenium supplementation. Chem Biol Interact 2006; 161: 49-56.
33. Tatematsu M, Mera Y, Ito N, Satoh K, Sato K,. Relative merits of immunohistochemical demonstrations of placental, A, B and C forms of glutathione S-transferase and histochemical demonstration of gamma-glutamyl transferase as markers of altered foci during liver carcinogenesis in rats. Carcinogenesis 1985; 11: 1621-6. (Pubitemid 16251957)
34. Schulte-Hermann R, Timmermann-Trosiener L, Barthel G, Bursch W,. DNA synthesis, apoptosis and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res 1990; 50: 5127-35. (Pubitemid 20257947)
35. Pascale RM, Simile MM, De Miglio MR, Muroni MR, Calvisi DF, Asara G, Casabona D, Frau M, Saddaiu MA, Feo F,. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis. Hepatology 2002; 35: 1341-50. (Pubitemid 34966888)
36. Lu SC, Mato JM,. S-adenosylmethionine in cell growth, apoptosis and liver cancer. J Gastroenterol Hepatol 2008; 23: S73-7. (Pubitemid 351389035)
37. Cai J, Mao Z, Hwang JJ, Lu SC,. Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells. Cancer Res 1998; 58: 1444-50. (Pubitemid 28193606)
38. Uemura T, Sai-Kato K, Takagi A, Hesegawa R, Kurokawa Y,. Oxidative DNA damage and cell proliferation in the livers of B6C3F1 mice exposed to pentachlorophenol in their diet. Fundam Appl Toxicol 1996; 30: 285-9.
39. Simile MM, Pascale R, De Miglio MR, Nufris A, Daino L, Seddaiu MA, Gaspa L, Feo F,. Correlation between S-adenosyl- L -methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. Cancer Lett 1994; 79: 9-16. (Pubitemid 24146715)
40. Tryndyak VP, Muskhelishvili L, Kovalchuk O, Rodriguez-Juarez R, Montgomery B, Churchwell MI, Ross SA, Beland FA, Pogribny IP,. Effect of long-term tamoxifen exposure on genotoxic and epigenetic changes in rat liver: implications for tamoxifen-induced hepatocarcinogenesis. Carcinogenesis 2006; 27: 1713-20. (Pubitemid 44288061)
41. Kim YI, Christman JK, Fleet JC, Cravo ML, Salomon RN, Smith D, Ordovas J, Selhub J, Mason JB,. Moderate folate deficiency does not cause global hypomethylation of hepatic and colonic DNA or c-myc-specific hypomethylation of colonic DNA in rats. Am J Clin Nutr 1995; 61: 1083-90.
42. Niu ZS, Li B-K, Wang M,. Expression of p53 and c-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissue. World J Gastroenterol 2002; 8: 822-6.
43. Nagy P, Evarts RP, Marden E, Roach J, Thorgeirsson SS,. Cellular distribution of c-myc transcripts during chemical hepatocarcinogenesis in rats. Cancer Res 1988; 48: 5522-7.
44. Kaposi-Novak P, Libbrecht L, Woo HG, Lee Y-H, Sears NC, Conner EA, Factor VM, Roskams T, Thorgeirsson SS,. Central role of c-myc during malignant conversion in human hepatocarcinogenesis. Cancer Res 2009; 69: 2775-82.
45. Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, Mandl S, Bachmann MH, Borowsky AD, Ruebner B, Cardiff RD, Yang Q, Bishop JM, Contag CH, Fesher DW,. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 2004; 431: 1112-17. (Pubitemid 39472236)
46. Purohit V, Abdelmalek MF, Barve S, Benevenga NJ, Halsted CH, Kaplowitz N, Kharbanda KK, Liu QY, Lu SC, McClain CJ, Swanson C, Zakhari S,. Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium. Am J Clin Nutr 2007; 86: 14-24. (Pubitemid 47041588)
47. Abdelmalek MF, Angulo P, Jorgensen RA, Sylvestre PB, Lindor KD,. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. Am J Gastroenterol 2001; 96: 2711-17.
48. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ,. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 2005; 82: 442-50.
49. Welzel TM, Katki HA, Sakoda LC, Evans AA, London WT, Chen G, O'Broin S, Shen FS, Lin W, McGlybb KA,. Blood folate levels and risk of liver damage and hepatocellular carcinoma in a prospective high-risk cohort. Cancer Epidemiol Biomarkers Prev 2007; 16: 1279-82. (Pubitemid 46984971)
50. Kuo CS, Lin CY, Wu MY, Lu CL, Huang RF,. Relationship between folate status and tumour progression in patients with hepatocellular carcinoma. Br J Nutr 2008; 100: 598-602.